A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge

Author： Tao T.   Skiadopoulos M.H.   Durbin A.P.   Davoodi F.   Collins P.L.   Murphy B.R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.9, 1999-03, pp. : 1100-1108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to P

By Tao T.   Davoodi F.   Cho C.J.   Skiadopoulos M.H.   Durbin A.P.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1359-1366

Elsevier

Access to resources Recommend Favorite

Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts

By H. Skiadopoulos M.   Tao T.   Surman S.R.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 503-510

Elsevier

Access to resources Recommend Favorite

Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV) - A meeting report of the WHO Programme for Vaccine Development

By Crowe J.E.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 415-421

Elsevier

Access to resources Recommend Favorite

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

By Skiadopoulos M.H.   Tatem J.M.   Surman S.R.   Mitcho Y.   Wu S.-L.   Elkins W.R.   Murphy B.R.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1846-1852

Elsevier

Access to resources Recommend Favorite

The bovine parainfluenza virus type-3 (BPIV-3) hemagglutinin/neuraminidase glycoprotein expressed in baculovirus protects calves against experimental BPIV-3 challenge

By Haanes E.J.   Guimond P.   Wardley R.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 730-738

Elsevier

Access to resources Recommend Favorite